These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32084321)

  • 21. Equivalence of complex drug products: advances in and challenges for current regulatory frameworks.
    Hussaarts L; Mühlebach S; Shah VP; McNeil S; Borchard G; Flühmann B; Weinstein V; Neervannan S; Griffiths E; Jiang W; Wolff-Holz E; Crommelin DJA; de Vlieger JSB
    Ann N Y Acad Sci; 2017 Nov; 1407(1):39-49. PubMed ID: 28445611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From design to the clinic: practical guidelines for translating cardiovascular nanomedicine.
    Cicha I; Chauvierre C; Texier I; Cabella C; Metselaar JM; Szebeni J; Dézsi L; Alexiou C; Rouzet F; Storm G; Stroes E; Bruce D; MacRitchie N; Maffia P; Letourneur D
    Cardiovasc Res; 2018 Nov; 114(13):1714-1727. PubMed ID: 30165574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of nanomedicine and nanosurgery.
    Singh S; Singh A
    Anesth Essays Res; 2013; 7(2):237-42. PubMed ID: 25885840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unique benefits of nanotechnology to drug delivery and diagnostics.
    McNeil SE
    Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diverse Applications of Nanomedicine.
    Pelaz B; Alexiou C; Alvarez-Puebla RA; Alves F; Andrews AM; Ashraf S; Balogh LP; Ballerini L; Bestetti A; Brendel C; Bosi S; Carril M; Chan WC; Chen C; Chen X; Chen X; Cheng Z; Cui D; Du J; Dullin C; Escudero A; Feliu N; Gao M; George M; Gogotsi Y; Grünweller A; Gu Z; Halas NJ; Hampp N; Hartmann RK; Hersam MC; Hunziker P; Jian J; Jiang X; Jungebluth P; Kadhiresan P; Kataoka K; Khademhosseini A; Kopeček J; Kotov NA; Krug HF; Lee DS; Lehr CM; Leong KW; Liang XJ; Ling Lim M; Liz-Marzán LM; Ma X; Macchiarini P; Meng H; Möhwald H; Mulvaney P; Nel AE; Nie S; Nordlander P; Okano T; Oliveira J; Park TH; Penner RM; Prato M; Puntes V; Rotello VM; Samarakoon A; Schaak RE; Shen Y; Sjöqvist S; Skirtach AG; Soliman MG; Stevens MM; Sung HW; Tang BZ; Tietze R; Udugama BN; VanEpps JS; Weil T; Weiss PS; Willner I; Wu Y; Yang L; Yue Z; Zhang Q; Zhang Q; Zhang XE; Zhao Y; Zhou X; Parak WJ
    ACS Nano; 2017 Mar; 11(3):2313-2381. PubMed ID: 28290206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Future perspectives for advancing regulatory science of nanotechnology-enabled health products.
    Halamoda-Kenzaoui B; Geertsma R; Pouw J; Prina-Mello A; Carrer M; Roesslein M; Sips A; Weltring KM; Spring K; Bremer-Hoffmann S
    Drug Deliv Transl Res; 2022 Sep; 12(9):2145-2156. PubMed ID: 35691982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality by design tools reducing the gap from bench to bedside for nanomedicine.
    Bonaccorso A; Russo G; Pappalardo F; Carbone C; Puglisi G; Pignatello R; Musumeci T
    Eur J Pharm Biopharm; 2021 Dec; 169():144-155. PubMed ID: 34662719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Standardisation in the field of nanotechnology: some issues of legitimacy.
    Forsberg EM
    Sci Eng Ethics; 2012 Dec; 18(4):719-39. PubMed ID: 21424592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurosurgery in the realm of 10(-9), Part 2: applications of nanotechnology to neurosurgery--present and future.
    Elder JB; Liu CY; Apuzzo ML
    Neurosurgery; 2008 Feb; 62(2):269-84; discussion 284-5. PubMed ID: 18382306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analytical Chemistry in the Regulatory Science of Medical Devices.
    Wang Y; Guan A; Wickramasekara S; Phillips KS
    Annu Rev Anal Chem (Palo Alto Calif); 2018 Jun; 11(1):307-327. PubMed ID: 29579404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Taiwan's strategies for regulating nanotechnology-based pharmaceuticals harmonized with international considerations.
    Guo JW; Lee YH; Huang HW; Tzou MC; Wang YJ; Tsai JC
    Int J Nanomedicine; 2014; 9():4773-83. PubMed ID: 25342901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanotechnology, bionanotechnology and microbial cell factories.
    Villaverde A
    Microb Cell Fact; 2010 Jul; 9():53. PubMed ID: 20602780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology.
    Domingues C; Santos A; Alvarez-Lorenzo C; Concheiro A; Jarak I; Veiga F; Barbosa I; Dourado M; Figueiras A
    ACS Nano; 2022 Jul; 16(7):9994-10041. PubMed ID: 35729778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging Applications of Nanotechnology in Healthcare and Medicine.
    Malik S; Muhammad K; Waheed Y
    Molecules; 2023 Sep; 28(18):. PubMed ID: 37764400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classification system for nanotechnology-enabled health products with both scientific and regulatory application.
    Rodríguez-Gómez FD; Penon O; Monferrer D; Rivera-Gil P
    Front Med (Lausanne); 2023; 10():1212949. PubMed ID: 37601794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of nanomedicine in cardiovascular diseases and stroke.
    Kim KS; Khang G; Lee D
    Curr Pharm Des; 2011; 17(18):1825-33. PubMed ID: 21631424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality by design (QbD) approach in marketing authorization procedures of Non-Biological Complex Drugs: A critical evaluation.
    Zagalo DM; Sousa J; Simões S
    Eur J Pharm Biopharm; 2022 Sep; 178():1-24. PubMed ID: 35908664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicines accessible in the market for clinical interventions.
    Gadekar V; Borade Y; Kannaujia S; Rajpoot K; Anup N; Tambe V; Kalia K; Tekade RK
    J Control Release; 2021 Feb; 330():372-397. PubMed ID: 33370576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of Standardizing Analytical Characterization Methodology for Improved Reliability of the Nanomedicine Literature.
    Sharifi S; Mahmoud NN; Voke E; Landry MP; Mahmoudi M
    Nanomicro Lett; 2022 Aug; 14(1):172. PubMed ID: 35987931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.